相关实验视频
Updated: Jul 6, 2026

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
7.0K
合成,在体外抗癌活性,分子对接,和动态模拟研究的thiazole-Conjugatedpyrazole衍生物的合成,在体外抗癌活性,分子对接,和动态模拟研究的thiazole-Conjugatedpyrazole衍生物
Deepali M Wanode1, Pramod B Khedekar1, Somdatta Y Chaudhari2
1Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, India.
Chemistry & biodiversity
|June 3, 2025
概括
合成了新型的zole-pyrazole混合化合物,并测试了对乳腺癌的抗癌活性. 化合物IVc显示出有前途的结果,表明乳腺癌新疗法的潜力.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌仍然是全球主要的死亡原因,需要开发新的治疗药物.
- 药的杂交是一种战略方法,用于发现具有增强生物活性的化合物.
- 提亚和皮拉部分因其多样化的药理性质而闻名,包括抗癌作用.
研究的目的:
- 设计和合成新型混合化合物,其中包括提亚和皮拉药.
- 为了评估这些杂交的体外抗癌活性与MCF-7乳腺癌细胞系.
- 研究最强效化合物的分子相互作用和药理动力学特性.
主要方法:
- 使用维尔斯迈耶-哈克反应合成混合化合物.
- 通过FTIR,1H NMR,13C NMR和高分辨率质谱法 (HRMS) 进行结构阐明.
- 使用MCF-7细胞系进行体外抗癌活性评估,并确定IC50值.
- 针对VEGFR-2激酶和分子动态模拟的分子对接研究.
- 用于制药动力学分析的ADMET (吸收,分布,新陈代谢,分泌,毒性) 预测.
主要成果:
- 成功合成和描述了新型的醇-皮拉醇混合化合物.
- 化合物IVc在体外对MCF-7细胞表现出显著的抗癌活性,IC50为126.98μM.
- 分子对接和模拟显示了化合物IVc与VEGFR-2激酶的稳定相互作用.
- 预测ADMET表明了有利的药理动力学特性,表明良好的药物相似性.
结论:
- 合成的 thiazole-pyrazole 混合物代表了乳腺癌治疗的有前途的化合物类别.
- 化合物IVc具有显著的抗癌潜力,需要进一步研究.
- 这项研究为基于 thiazole-pyrazole 支架的新型抗癌药物的合理设计提供了基础.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Phase II Conjugation Reactions: Overview
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
Phase II Reactions: Miscellaneous Conjugation Reactions
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...

